Articles
25.10.2022
How is International Reference Pricing used within...

We discuss the advantages and disadvantages of using international reference pricing for consistent ...

Read more
Articles
18.10.2022
What are the pricing considerations when launching...

We explore the pricing dynamics of biosimilars, which depend on the type of biosimilar, its indicati...

Read more
Articles
12.10.2022
How important is HTA when launching a biosimilar i...

The short answer to the question “how important is HTA when launching a biosimilar in the EU5?” ...

Read more
Insider Insights
05.10.2022
Germany: Experts criticise the GKV’s financial s...

On 28th September there was a two-hour public hearing on the GKV Financial Stabilisation Act. There ...

Read more

Stay in the know, subscribe to our newsletter

Be the first to receive exclusive content on the latest from the pharmaceutical and market access sector.